CU20110034A7 - THERAPEUTIC AGENTS 414 - Google Patents
THERAPEUTIC AGENTS 414Info
- Publication number
- CU20110034A7 CU20110034A7 CU20110034A CU20110034A CU20110034A7 CU 20110034 A7 CU20110034 A7 CU 20110034A7 CU 20110034 A CU20110034 A CU 20110034A CU 20110034 A CU20110034 A CU 20110034A CU 20110034 A7 CU20110034 A7 CU 20110034A7
- Authority
- CU
- Cuba
- Prior art keywords
- therapeutic agents
- formula
- glk
- glucokinase
- sequestration
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000030595 Glucokinase Human genes 0.000 abstract 1
- 108010021582 Glucokinase Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000009919 sequestration Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un compuesto de fórmula (I): ESPACIO PARA LA FÓRMULA es útil en el tratamiento o prevención de una enfermedad o afección médica mediada por glucoquinasa (GLK o GK), que conduce a una reducción del umbral de glucosa para la secresión de insulina.A compound of formula (I): SPACE FOR FORMULA is useful in the treatment or prevention of a disease or medical condition mediated by glucokinase (GLK or GK), which leads to a reduction of the glucose threshold for insulin sequestration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110034A CU20110034A7 (en) | 2011-02-04 | 2011-02-04 | THERAPEUTIC AGENTS 414 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110034A CU20110034A7 (en) | 2011-02-04 | 2011-02-04 | THERAPEUTIC AGENTS 414 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20110034A7 true CU20110034A7 (en) | 2011-12-28 |
Family
ID=45508742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20110034A CU20110034A7 (en) | 2011-02-04 | 2011-02-04 | THERAPEUTIC AGENTS 414 |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20110034A7 (en) |
-
2011
- 2011-02-04 CU CU20110034A patent/CU20110034A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2011000047A (en) | THERAPEUTIC AGENTS 414 | |
| BR112014003198A2 (en) | compounds for the treatment and prophylaxis of respiratory syncytial virus disease | |
| EA201991014A1 (en) | DIABETES TREATMENT | |
| CO6821938A2 (en) | A guanidine compound or salt thereof for the treatment of diseases related to vap -1 | |
| CR10564A (en) | FUSIONATED CYCLIC COMPOUNDS | |
| MX2013006113A (en) | Bicyclic compound. | |
| CR20120448A (en) | HETEROCYCLIC COMPOUND | |
| CR20130377A (en) | DRUG METHODS AND PRODUCTS TO TREAT ALZHEIMER'S DISEASE | |
| MX356728B (en) | Pharmaceutical combination for use in the treatment of diabetes type 2. | |
| CO6781497A2 (en) | Treatment for lipodystrophy | |
| PH12017500747B1 (en) | Heterocyclic compound | |
| MX2014002112A (en) | Pyrimido- pyridazinone compounds and use thereof. | |
| BR112015026238A2 (en) | cancer treatment with dihydropyrazine pyrazines | |
| DOP2012000058A (en) | THERAPEUTIC AGENT FOR DISORDERS OF THE STATE OF ANIMO | |
| BR112014011223A2 (en) | method of treating a proliferative disease | |
| MX349254B (en) | Compounds for treatment of metabolic syndrome. | |
| CL2011001943A1 (en) | Antibiotic therapy to treat or prevent post-infectious irritable bowel syndrome. | |
| MX2017003780A (en) | PHARMACEUTICAL COMPOSITION TO TREAT ULCERATIVE COLITIS. | |
| CR20110552A (en) | TREATMENT OF INSULIN RESISTANT DISORDERS | |
| BR112014008783A2 (en) | compounds for the treatment and prophylaxis of respiratory syncytial virus disease | |
| AR082278A1 (en) | ENTEROVIRUS VACCINES TO PREVENT OR TREAT TYPE 1 DIABETES (III) | |
| DOP2010000156A (en) | OXAZOLIDINONES FOR THE TREATMENT AND / OR PROFILAXIS OF CARDIAC INSUFFICIENCY | |
| DOP2012000056A (en) | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | |
| UY32550A (en) | "(2S) -2- [1- (2,6-DICLOROPHENYL) PIRAZOLO [4,5-E] PYRIMIDIN-4-IL] OXI-3- (3-HYDROXIAZETIDIN-1-IL) -N- (5- METHYLPIRAZIN-2-IL) PROPANAMIDE | |
| MY182801A (en) | Compound for activating ampk and uses thereof |